Biotechnology Adding to mega-dollar deals signed last month with the governments of the USA, UK and Japan for supplies of their COVID-19 vaccine candidate, US pharma giant Pfizer and Germany’s BioNTech today announced an agreement with the government of Canada to supply their BNT162 mRNA-based vaccine candidate against SARS-CoV-2, subject to clinical success and Health Canada approval. 5 August 2020